Despite many advances in the antimicrobial therapy of various infectious diseases, sepsis remains a significant cause of morbidity and mortality in hospitalized patients ( 1-3). The usual clinical course of sepsis progresses from unrecognized infection through a period of clinically apparent infection with signs and symptomsof systemic inflammatory responses to a lifethreatening condition of septic shock and multiple organ failure (4). According to our recent observation in patients with systemic inflammatory response syndrome (SIRS), there were stepwise increases in mortality rates in the progression from sepsis to severe sepsis, and finally septic shock; the mortality rates being 30.6 per cent, 53.3 per cent, and 64.0 per cent, respectively (1). For many years it has been known that early recognition of the systemic inflammatory signs associated with infection and prompt detection of the blood-borne pathogens are mandatory for reducing the mortality of sepsis. In a study on surgical sepsis, Wilson demonstrated that if sepsis was not diagnosed and operated upon aggressively prior to the development of shock or organ failure, the mortality rate rose from 12 per cent to 64 -88 per cent (5). In addition, a delayed antibiotic therapy would increase the mortality of sepsis (6). In this issue of Internal Medicine, Dr. Aoki and colleagues (7) present the epidemiology of sepsis patients and practice of their managementin a tertiary care teaching hospital in Japan.
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In a prospective observational study, they have reviewed 73 patients whohad a positive blood culture and whomet the diagnosis criteria of sepsis proposed by the Consensus Conference of the American College of Chest Physicians and Society of Critical Care Medicine (8) . By using this definitive enrollment criteria in this prospective study, the authors could select rather a homogenous population of "bacteremic sepsis" than a population of simple "sepsis" that includes a broad spectrum and different severity of patients with infectious diseases (8, 9) . The "bacteremic sepsis" in this study could be called "septicemia", but this medical term is becoming obsolete after the Consensus Conference recommendedthat the term not be used (8) .
It must be pointed out that the patients enrolled in this study (7) were treated in non-ICU wards of different clinical services by physicians who were not specialized in infectious diseases. As in most Japanese teaching hospitals where an independent subspecialty of infectious diseases does not exist, their hospital had no resource of infectious disease consultation services.
In this study, the overall mortality rate was 34 per cent. Fiftysix patients (77%) had hospital-acquired sepsis that developed while the patient was hospitalized for medical problems other than sepsis. Methicillin-resistant Staphylococcus aureus (MRSA)was isolated by blood culture in eleven patients of which six patients (55%) died. Twenty-three patients (32%) had septic shock, and it is not surprising that the mortality rate of patients with septic shock was 52 per cent that was much higher than that of non-shock patients (26%). Although the patients were treated without a consultation service of infectious disease specialists and intensive care physicians, the overall outcomeof the sepsis patients in this study was in an acceptable range as comparedwith the mortality rates shown in other sepsis studies (1-3). However, if these patients had been managedwith an involvement of these specialists, the development of hospital-acquired sepsis and septic shock could have been reduced and the outcomeof the bacteremic sepsis could have been better. As pointed out in this paper, it seems that the physicians (or surgeons) did not pay too much attention to their patients when clinically defined sepsis developed. Out of four vital signs (pulse rate, blood pressure, body temperature, and respiratory rate) of the sepsis patients, the physicians recorded in a chart only 1.67 vital signs on average.
The first blood culture sampling was delayed until two to three days after the onset of sepsis, and the meannumberof blood cultures taken was 1.5 in the entire course of sepsis. Only 21 patients (29%) had a multiple set blood cultures. The reasons for this rather unsatisfactory practice for an early diagnosis of bacteremic sepsis are obvious. The doctor who has to take care of sepsis patients in that hospital could be a hematologist, a neurologist, a cardiologist, a general surgeon, or even a cardiac surgeon, whohas limited knowledge and experience in the managementof sepsis. Furthermore, routine consultation with an infectious disease specialist was not available. I regret to admit that this is rather a commonpractice in manyof the Japanese teaching hospitals including our hospital in Tokyo.
In 1995 the Japanese Association for Infectious Diseases established a programto certify a trained memberof the association to be a fellow. association whose primary specialty is either internal medicine or pediatrics. In addition, a committee sponsored by 12 infection-related academic societies in Japan is recognizing the position of "an infection control doctor (ICD)", and 1, 121 doctors have been certified to date. The introduction of these "infectious disease specialists", however, has basically not changed the clinical practice of infection managementto date, as few specialists are working full-time for infectious disease consultation. Fewinfection fellow membersor ICDs are asked for his/her recommendation for the diagnosis and treatment of infectious diseases by other doctors. In most institutions in Japan, whena nosocomial surgical infection develops in a postoperative patient, it is customary for the surgeon who operated on that particular patient to decide the antimicrobial therapy and no other professional would makecommentson the surgeon's decision. However,we knowwell that modernmanagement of sepsis patients requires an involvement of many specialists (10).
In an era of growing resistant pathogens and increasing nosocomial infections, it is high time change our mind and introduce a truly workable system of infectious diseases subspecialty and consultation services into Japanese practice of medi- 
